hotspot -WSS

hotspot

author：entertainment 2025-08-04 12:36:02 - browse：2533

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： All of Us, NIH's precision medicine initiative, gets a big boost

hotspot

WSS

Key Senate panel to consider PBM, drug pricing reform package

How to convince healthy people to buy insurance

Headspace, Meta partner to launch VR meditation app for Quest

Medicare proceeds with plan to claw back hospital funds

Key Senate panel to consider PBM, drug pricing reform package

Air quality improving but still lags in Black, Hispanic communities

leisure time

hotspot

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Change Healthcare cyberattack prompts Medicare loan program

Moonlake's readout produced a cash windfall. Risks remain

After Sarepta trial failure, Duchenne families brace for more debate

Medicare proposal to cover medical devices draws a mixed reaction

Infant mortality in U.S. rose last year for first time in decades: CDC

Walensky prepares to leave CDC — and Congress — behind

How to bring more disabled researchers into academia

Continuity nursing helped my family in our darkest PICU moments

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

hotspot

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Coloradans with cystic fibrosis could lose access to Trikafta

Precocious puberty in girls comes with mental health risks

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

With psoriasis trial ahead, Alumis raises $259 million

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

hotspot

hotspot

focus

focus